Table 4.
LncRNAs as prognostic biomarkers in gastric cancer
| Clinical application | LncRNA | Expression | Clinical significance | Reference |
|---|---|---|---|---|
| Prognostic biomarker |
CASC19 | up | Higher pathologic TNM stage, pathologic T stage, lymph node metastasis, and poor overall survival |
173 |
| SNHG6 | up | Invasion depth, lymph node metastasis, distant metastasis and TNM stage | 182 | |
| MIR100HG | up | TNM stage, tumor invasion, lymph node metastasis, and distant metastasis | 183 | |
| Sox2ot | up | TNM stage, tumor depth, lymph node metastasis, and distant metastasis | 184 | |
| MALAT1 | up | Distant metastasis | 185 | |
| NEAT1 | up | Clinical stage, histological type, lymph node metastasis, and distant metastasis | 174 | |
| SNHG8 | up | Predicts poor prognosis, shorter survival time | 186 | |
| CTD-2510F5.4 | Pathological grade, vascular or nerve invasion, AJCC TNM stage and OS, shorter MST | 187 |